Search Results - "Egawa, H."

Refine Results
  1. 1

    How Close Can We Get to the Edge of the Cliff? by Egawa, H.

    Published in American journal of transplantation (01-06-2016)
    “…The author addresses innovations in living donor liver transplantation and warns of advancing efforts to expand the liver donor pool at the risk of donor…”
    Get full text
    Journal Article
  2. 2

    Impact of Rituximab Desensitization on Blood‐Type‐Incompatible Adult Living Donor Liver Transplantation: A Japanese Multicenter Study by Egawa, H., Teramukai, S., Haga, H., Tanabe, M., Mori, A., Ikegami, T., Kawagishi, N., Ohdan, H., Kasahara, M., Umeshita, K.

    Published in American journal of transplantation (01-01-2014)
    “…We evaluated the effects of rituximab prophylaxis on outcomes of ABO‐blood‐type‐incompatible living donor liver transplantation (ABO‐I LDLT) in 381 adult…”
    Get full text
    Journal Article
  3. 3

    Current Status of Organ Transplantation in Japan by Egawa, H., Tanabe, K., Fukushima, N., Date, H., Sugitani, A., Haga, H.

    Published in American journal of transplantation (01-03-2012)
    “…To overcome severe donor shortage, Japanese doctors over the years have developed innovative strategies to maximize organs transplanted per brain death donor…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Long‐Term Outcomes of Living‐Donor Liver Transplantation for Primary Biliary Cirrhosis: A Japanese Multicenter Study by Egawa, H., Sakisaka, S., Teramukai, S., Sakabayashi, S., Yamamoto, M., Umeshita, K., Uemoto, S.

    Published in American journal of transplantation (01-04-2016)
    “…The factors that influence long‐term outcomes after living‐donor liver transplantation (LDLT) for primary biliary cirrhosis (PBC) are not well known. Compared…”
    Get full text
    Journal Article
  6. 6

    Portal Vein Complications in Pediatric Living Donor Liver Transplantation Using Left‐Side Grafts by Ueda, M., Oike, F., Kasahara, M., Ogura, Y., Ogawa, K., Haga, H., Takada, Y., Egawa, H., Tanaka, K., Uemoto, S.

    Published in American journal of transplantation (01-10-2008)
    “…The aim of this report is to assess the rate of portal vein complications (PVCs), the success rate of treatment for PVCs and the prognosis of patients with…”
    Get full text
    Journal Article
  7. 7

    Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Living Donor Liver Transplantation in Japanese Registry by Egawa, H., Ueda, Y., Ichida, T., Teramukai, S., Nakanuma, Y., Onishi, S., Tsubouchi, H.

    Published in American journal of transplantation (01-03-2011)
    “…The outcomes of primary sclerosing cholangitis (PSC) after living donor liver transplantation (LDLT) in a large series have not been reported. We aimed to…”
    Get full text
    Journal Article
  8. 8

    In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705 by FURUTA, Y, TAKAHASHI, K, NARITA, H, SHIRAKI, K, FUKUDA, Y, KUNO, M, KAMIYAMA, T, KOZAKI, K, NOMURA, N, EGAWA, H, MINAMI, S, WATANABE, Y

    Published in Antimicrobial Agents and Chemotherapy (01-04-2002)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  9. 9

    Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells by Smee, Donald F., Hurst, Brett L., Egawa, Hiroyuki, Takahashi, Kazumi, Kadota, Takumi, Furuta, Yousuke

    Published in Journal of antimicrobial chemotherapy (01-10-2009)
    “…Objectives To determine the metabolism of favipiravir (T-705, 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) to its ribosylated, triphosphorylated form (T-705 RTP)…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Practices for Supporting and Confirming Decision‐Making Involved in Kidney and Liver Donation by Related Living Donors in Japan: A Nationwide Survey by Nishimura, K., Kobayashi, S., Tsutsui, J., Kawasaki, H., Katsuragawa, S., Noma, S., Kimura, H., Egawa, H., Yuzawa, K., Umeshita, K., Aikawa, A., Uemoto, S., Takahara, S., Ishigooka, J.

    Published in American journal of transplantation (01-03-2016)
    “…This nationwide survey investigated the actual practices for supporting and confirming the decision‐making involved in related living‐organ donations in Japan,…”
    Get full text
    Journal Article
  15. 15

    Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients by Fukudo, Masahide, Yano, Ikuko, Masuda, Satohiro, Goto, Maki, Uesugi, Miwa, Katsura, Toshiya, Ogura, Yasuhiro, Oike, Fumitaka, Takada, Yasutsugu, Egawa, Hiroto, Uemoto, Shinji, Inui, Ken‐ichi

    Published in Clinical pharmacology and therapeutics (01-10-2006)
    “…Objective Our objective was to investigate the population pharmacokinetics of tacrolimus in pediatric living‐donor liver transplant recipients and examine the…”
    Get full text
    Journal Article
  16. 16

    Long‐Term Outcome of Adult‐to‐Adult Living Donor Liver Transplantation for Post‐Kasai Biliary Atresia by Uchida, Y., Kasahara, M., Egawa, H., Takada, Y., Ogawa, K., Ogura, Y., Uryuhara, K., Morioka, D., Sakamoto, S., Inomata, Y., Kamiyama, Y., Tanaka, K.

    Published in American journal of transplantation (01-10-2006)
    “…Our objective was to analyze problems in the perioperative management and long‐term outcome of living donor liver transplantation (LDLT) for biliary atresia…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Portal Vein Complications in the Long-Term Course After Pediatric Living Donor Liver Transplantation by Ueda, M., Egawa, H., Ogawa, K., Uryuhara, K., Fujimoto, Y., Kasahara, M., Ogura, Y., Kozaki, K., Takada, Y., Tanaka, K.

    Published in Transplantation proceedings (01-03-2005)
    “…The frequency and the outcome of patients with portal vein (PV) complications in the long-term course after pediatric living donor liver transplantation (LDLT)…”
    Get full text
    Journal Article Conference Proceeding
  19. 19
  20. 20